PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,344 | -46.0% | 61,600 | -21.3% | 0.00% | 0.0% |
| Q2 2023 | $352,350 | -31.5% | 78,300 | -13.2% | 0.00% | -50.0% |
| Q1 2023 | $514,140 | -15.2% | 90,200 | -10.2% | 0.00% | 0.0% |
| Q4 2022 | $606,416 | -15.9% | 100,400 | -8.0% | 0.00% | 0.0% |
| Q3 2022 | $721,000 | +8.6% | 109,100 | -14.2% | 0.00% | 0.0% |
| Q2 2022 | $664,000 | +29.2% | 127,200 | +70.7% | 0.00% | +100.0% |
| Q1 2022 | $514,000 | +209.6% | 74,500 | +460.2% | 0.00% | – |
| Q4 2021 | $166,000 | -60.1% | 13,300 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $416,000 | +9.2% | 13,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $381,000 | -33.9% | 13,300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $576,000 | – | 13,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |